Bioactive Compound Profiling and Pharmacological Evaluation

Bioactive compound profiling and pharmacological evaluation constitute an integrated framework for the discovery, characterisation and functional assessment of naturally derived molecules. Profiling techniques such as gas chromatography–mass spectrometry (GC-MS), liquid chromatography–tandem mass spectrometry (LC-MS/MS) and nuclear magnetic resonance spectroscopy yield detailed chemical fingerprints of complex extracts from plants, animals or microbial sources. These data guide the isolation of individual constituents, whose structures are confirmed by spectroscopic and chromatographic methods including high-performance liquid chromatography (HPLC) and Fourier transform infrared spectroscopy (FTIR). Once characterised, compounds are subjected to a battery of pharmacological assays, encompassing in vitro screens for antioxidant capacity, enzyme inhibition and antimicrobial activity, in vivo models for anti-inflammatory and antipyretic effects, and in silico molecular docking to predict target engagement. This multidisciplinary approach accelerates the identification of lead candidates for drug development, addresses the urgent need for new therapeutics against metabolic disorders, infectious diseases and chronic inflammation, and harnesses biodiversity for sustainable health solutions.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies have illuminated novel sources of bioactive compounds and advanced pharmacological evaluation. Investigations of quail egg yolk oil employed GC-MS and FTIR to quantify fourteen major antioxidant and anti-inflammatory constituents. Toxicity assays in Drosophila revealed no adverse effects, while gene-expression analysis demonstrated upregulation of catalase and modulation of inflammatory mediators, underscoring the oil’s potential as a nutraceutical and cosmetic ingredient. Work on Ficus palmata Forssk. combined GC-MS phytochemical profiling with in vitro and in silico assays, identifying twenty-seven phytocompounds including triterpenes and steroids. The extract exhibited strong α-glucosidase inhibition, moderate α-amylase inhibition, and significant antimicrobial and anticancer activities, with molecular docking and ADMET prediction highlighting drug-like candidates for antidiabetic and antimicrobial applications. A comprehensive evaluation of Oxystelma esculentum integrated HPLC quantification of phenolics, in vitro lipoxygenase inhibition and human red blood cell membrane stability assays, in vivo carrageenan-induced paw oedema and analgesic models, and molecular docking. Several phenolic acids displayed binding affinities comparable with clinical anti-inflammatory agents, supporting the plant’s traditional use and informing future lead optimisation.

Bioactive Compound Profiling and Pharmacological Evaluation publication trend

The graph below shows the total number of articles in bioactive compound profiling and pharmacological evaluation across all publications each year (not limited to Nature Index journals).

Technical terms

Gas chromatography–mass spectrometry (GC-MS): Analytical technique that separates volatile compounds and identifies them by mass spectral fragmentation.

Liquid chromatography–tandem mass spectrometry (LC-MS/MS): High-sensitivity method for separating and characterising non-volatile molecules through multiple rounds of mass analysis.

High-performance liquid chromatography (HPLC): Chromatographic technique for quantifying and purifying compounds based on their interactions with a stationary phase under high pressure.

Molecular docking: Computational modelling that predicts the preferred orientation of a small molecule when bound to a protein target.

In vitro assays: Laboratory tests conducted in controlled environments such as cell cultures or enzyme preparations.

In vivo models: Experiments carried out in living organisms to assess pharmacological efficacy and safety.

References

1. Antioxidant and Anti-Inflammatory Properties of Quail Yolk Oil via Upregulation of Superoxide Dismutase 1 and Catalase Genes and Downregulation of EIGER and Unpaired 2 Genes in a D. melanogaster Model. Antioxidants (2024).
2. Phytochemical, Antimicrobial, Antidiabetic, Thrombolytic, anticancer Activities, and in silico studies of Ficus palmata Forssk. Arabian Journal of Chemistry (2023).
3. Anti-inflammatory, analgesic, and antipyretic potential of Oxystelma esculentum (L. f.) Sm. using in vitro, in vivo, and in silico studies. Frontiers in Pharmacology (2024).